Chemical composition and in vitro antiobesity and in vivo anti-hyperlipidemic effects of Ceratotheca sesamoides, Jatropha tanjorensis, Mucuna flagellipes, Pterocarpus mildbraedii and Piper guineense
Ethnopharmacological relevance: Ceratotheca sesamoides, Jatropha tanjorensis, Mucuna flagellipes, Pterocarpus mildbraedii and Piper guineense are all medicinal plants found in West Africa and used traditionally for the treatment of various ailments such as; hypertension, arteriosclerosis, anemia, ma...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_5f5532bac3cb49f7941ed255e9aae3c2 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Gabriel O. Anyanwu |e author |
700 | 1 | 0 | |a Dorathy Anzaku |e author |
700 | 1 | 0 | |a Chinda C. Donwell |e author |
700 | 1 | 0 | |a Usunomena Usunobun |e author |
700 | 1 | 0 | |a Ademuyiwa J. Adegbegi |e author |
700 | 1 | 0 | |a Patricia C. Ofoha |e author |
700 | 1 | 0 | |a Khalid Rauf |e author |
245 | 0 | 0 | |a Chemical composition and in vitro antiobesity and in vivo anti-hyperlipidemic effects of Ceratotheca sesamoides, Jatropha tanjorensis, Mucuna flagellipes, Pterocarpus mildbraedii and Piper guineense |
260 | |b Elsevier, |c 2021-08-01T00:00:00Z. | ||
500 | |a 2667-0313 | ||
500 | |a 10.1016/j.phyplu.2021.100042 | ||
520 | |a Ethnopharmacological relevance: Ceratotheca sesamoides, Jatropha tanjorensis, Mucuna flagellipes, Pterocarpus mildbraedii and Piper guineense are all medicinal plants found in West Africa and used traditionally for the treatment of various ailments such as; hypertension, arteriosclerosis, anemia, malaria and flatulence. Aim of the study: The purpose of this study is to ascertain the in vitro anti-obesity and in vivo anti-hyperlipidemic activity of extracts and fractions of selected plants. Materials and methods: The ethanolic extract of the aforementioned five plants were tested in vitro for their activity against porcine pancreatic lipase and alpha-amylase at a concentration of 1mg/ml. Thereafter, the IC50 values of the plants active against alpha-amylase were determined. The ethanolic extract of P. mildbraedii and M. flagellipes were fractionated using n-hexane, n-butanol, ethyl acetate and water, thus the four fractions each obtained were used for further in vitro and in vivo studies. Thirty-five male rats were divided into seven groups out of which groups 2-7 were made hyperlipidemic using poloxamer 407 (1.0 g/kg body weight) intraperitoneally. Groups 1, 2 and 3 were the normal, hyperlipidemic and standard drug control groups respectively, whereas groups 4-7 were the test groups. Results: C. sesamoides, M. flagellipes and P. mildbraedii inhibited alpha-amylase activity, while M. flagellipes and P. mildbraedii had activity against pancreatic lipase. The n-hexane fraction of P. mildbraedii and M. flagellipes inhibited both lipase and amylase enzyme activities among the four fractions of each plant tested. The GCMS analysis of n-hexane fractions revealed the presence of two major compounds in each plant which were 9-octadecenoic acid and hexadecanoic acid in P. mildbraedii, and hexadecanoic acid and 9,12-octadecadienoic acid in M. flagellipes. The in vivo studies revealed that the n-hexane fraction of P. mildbraedii and M. flagellipes significantly decreased (p < 0.05) total triglycerides, total cholesterol, and low density lipoprotein cholesterols when compared to the hyperlipidemic control rats. Conclusions: P. mildbraedii and M. flagellipes have the potency to act as antiobesity and anti-hyperlipidemic agents. | ||
546 | |a EN | ||
690 | |a Hyperlipidemia | ||
690 | |a Amylase | ||
690 | |a Lipase | ||
690 | |a Antiobesity | ||
690 | |a Mucuna flagellipes | ||
690 | |a Pterocarpus mildbraedii | ||
690 | |a Other systems of medicine | ||
690 | |a RZ201-999 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Phytomedicine Plus, Vol 1, Iss 3, Pp 100042- (2021) | |
787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2667031321000245 | |
787 | 0 | |n https://doaj.org/toc/2667-0313 | |
856 | 4 | 1 | |u https://doaj.org/article/5f5532bac3cb49f7941ed255e9aae3c2 |z Connect to this object online. |